Research Analysts Set Expectations for FIGS Q4 Earnings

FIGS, Inc. (NYSE:FIGS) – Analysts at Roth Capital decreased their Q4 2024 earnings per share estimates for FIGS in a research report issued on Monday, November 4th. Roth Capital analyst M. Koranda now expects that the company will earn $0.03 per share for the quarter, down from their prior forecast of $0.04. The consensus estimate for FIGS’s current full-year earnings is $0.03 per share. Roth Capital also issued estimates for FIGS’s Q4 2025 earnings at $0.06 EPS and FY2026 earnings at $0.20 EPS.

FIGS (NYSE:FIGS) last issued its quarterly earnings results on Thursday, August 8th. The company reported $0.01 earnings per share (EPS) for the quarter. The business had revenue of $144.23 million for the quarter, compared to analysts’ expectations of $142.25 million. FIGS had a net margin of 3.39% and a return on equity of 4.94%. The business’s quarterly revenue was up 4.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.02 earnings per share.

FIGS has been the topic of a number of other reports. Telsey Advisory Group reissued a “market perform” rating and issued a $7.00 price objective on shares of FIGS in a research report on Monday. The Goldman Sachs Group lifted their price target on shares of FIGS from $4.25 to $4.75 and gave the stock a “sell” rating in a research note on Friday, August 9th. Two research analysts have rated the stock with a sell rating, three have given a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat.com, FIGS currently has a consensus rating of “Hold” and a consensus target price of $5.60.

FIGS Trading Up 1.9 %

FIGS stock opened at $6.33 on Tuesday. FIGS has a twelve month low of $4.30 and a twelve month high of $7.98. The firm has a market capitalization of $1.08 billion, a P/E ratio of 63.30, a P/E/G ratio of 83.33 and a beta of 1.44. The stock’s fifty day simple moving average is $6.16 and its 200-day simple moving average is $5.70.

Institutional Trading of FIGS

Hedge funds have recently added to or reduced their stakes in the stock. Creative Planning lifted its holdings in FIGS by 17.7% in the third quarter. Creative Planning now owns 12,697 shares of the company’s stock valued at $87,000 after acquiring an additional 1,911 shares during the period. The Manufacturers Life Insurance Company grew its position in FIGS by 6.0% during the second quarter. The Manufacturers Life Insurance Company now owns 50,564 shares of the company’s stock worth $270,000 after buying an additional 2,879 shares during the period. Janney Montgomery Scott LLC increased its holdings in FIGS by 23.6% in the first quarter. Janney Montgomery Scott LLC now owns 16,977 shares of the company’s stock valued at $85,000 after buying an additional 3,247 shares in the last quarter. Price T Rowe Associates Inc. MD boosted its stake in shares of FIGS by 6.8% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 63,141 shares of the company’s stock worth $316,000 after acquiring an additional 4,038 shares in the last quarter. Finally, Tandem Capital Management Corp ADV raised its holdings in FIGS by 3.3% during the second quarter. Tandem Capital Management Corp ADV now owns 133,330 shares of the company’s stock worth $725,000 after purchasing an additional 4,200 shares during the last quarter. 92.21% of the stock is owned by institutional investors and hedge funds.

FIGS Company Profile

FIGS, Inc operates as a direct-to-consumer healthcare apparel and lifestyle company in the United States and internationally. It designs and sells healthcare apparel and scrubwear and non-scrubwear offerings, such as outerwear, underscrubs, footwear, compression socks, lab coats, loungewear, and other apparel.